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A conspicuous amount of knowledge about the molecular biol-
ogy of the cell has come from studies on yeast Saccharomyces cere-
visiae, mostly because of its unrivaled qualities as a toolkit for
molecular genetics study. The discovery in the late 90’s that this
unicellular eukaryote alsomay activate cell death programs both
physiologically, like mammalian apoptotic cell death (Madeo,
Frohlich and Frohlich 1997), and under environmental stress,
completed the yeast-toolkit. The first thematic issue on this
topic of FEMS Yeast Research four years ago witnessed the no-
ticeable amount of research carried out to get a deeper insight
into the mechanisms of fundamental biological processes, al-
ready discovered in yeast, such as genetic stability and expres-
sion, cell cycle, organelle biogenesis and cross-talk. Indeed, it
has been possible to study these processes with the added di-
mension to discover their function and interrelationships in cell
homeostasis maintenance considering also the effect of envi-
ronmental cues.
Although debated by the scientific community, the field of
yeast regulated cell death research has been expanding to more
andmore bio-medical research themes, including aging, human
diseases, cell stress response and metabolism. Research on age-
ing is one of the topmedical priorities in developed societies and
yeast represents an attractive model system for studying more
complex phenomena that occur in higher eukaryotic cells, in-
cluding cell division, ageing and apoptosis. While such research
in a clinical setting is confronted with—and limited by—ethical
issues, and since studying ageing, longevity and regulated cell
death in metazoan models is time consuming and costly, yeast
cells offer an attractive eukaryotic model.
Although it is now clear that yeast can indeed undergo cellu-
lar suicide, the corresponding terminology to describe this mul-
tifaceted process remains heterogeneous and potentially mis-
leading. Thus, following the directions of the Nomenclature
Committee on Cell Death (NCCD) and adapting them to the par-
ticularities of S. cerevisiae, the yeast cell death research commu-
nity has recently proposed unified criteria for the definition of
accidental, regulated and programmed forms of cell death in
yeast based on a series of morphological and biochemical crite-
ria (Carmona-Gutierrez et al. 2018). This has clearly defined for
the first time the concept of ‘yeast cell death’, with significant
progress being made at the phenotypical and mechanistic lev-
els, including the finding that, similarly to higher eukaryotes,
yeast can also engage in distinct cell death modalities.
The second scientific revolution of S. cerevisiae as a model or-
ganism for fundamental academic research as well as a biofac-
tory for a wide range of industrial applications is already under
way. On one hand, postgenomic systems biology research has
been focusing on the global mapping of genetic interaction net-
works. The systematic analysis of trigenic interactions in yeast,
invented and developed in the laboratory of Charles Boone at the
University of Toronto, is definitely laying the basis for the first
successful opportunity to modelling a cell (Kuzmin et al. 2018).
On the other hand, the international Synthetic Yeast Genome
Project, known as Yeast 2.0 or Sc2.0, is to create a fully man-
made genome for S. cerevisiae in order to better understand the
biological intricacies of eukaryotic semi-synthetic organisms.
This will allow tomore accurately predict and control the practi-
cal outcomes of genome engineering—as opposed to individual
gene-based genetic engineering (Pretorius 2017).
Despite these promising developments, elucidation of the
mechanisms and identification of molecules controlling the in-
tricate network, which regulates cell homeostasis is still an ur-
gent necessity, in order to fully grasp the benefits of a holis-
tic approach to biomedical and biotechnological research. Thus,
this thematic issue is a showcase for cutting-edge achieve-
ments in the knowledge on the molecular basis of many fun-
damental cellular processes governing cell homeostasis, thus
highlighting the new age of yeast research in biomedicine and
biotechnology. In particular, special attention is paid to molec-
ular mechanisms of ageing and regulated cell death, pointing
to yeast as a valuable model for studying the onset of dis-
eases and for screening/design drugs able to interfere with these
pathologies.
In this second thematic issue on yeast aging and cell death
of FEMS Yeast Research we have collected and edited six Mini Re-
views that provide an overview of cutting-edge research on fun-
damental processes, including RNA stability, nutrient sensing,
proteostasis, lipotoxicity, mitochondrial–cytosol–nucleus com-
munications and aging. Threemini-reviews dealwith yeastmul-
ticellular communities, the potential of yeast mitochondria to
develop mitochondrial systems biology and the use of yeast as
a platform for anti-aging drug discovery.
Obesity and overweight are the adverse effects of excessive
nutrition and they can be associated with metabolic alterations
leading to metabolic syndrome. Although the exact etiology of
metabolic syndrome is not known, unbalanced lipidmetabolism
in non-adipose tissues is considered to contribute to lipotoxicity,
The use of yeast has provided important insights into the toxi-
city associated with exposure to excess fatty acids (FAs), diacyl-
glycerol (DGs), sterols and ceramides. The minireview by Rock-
enfeller and Gourlay (doi: 10.1093/femsyr/foy034) recapitulates
recent research advances on the Rim101 pathway and mem-
brane contact sites in the context of lipotoxicity in yeast and
offers an outlook for future research directions.
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The RNA world comprises a broad class of molecules with
different cellular functions, which are mainly classified as cod-
ing and non-coding RNAs. Both play different structural or func-
tional roles within the cell and, for this reason, the study of RNA
metabolism, including regulation, modification and stability of
transcripts, represents a crucialmilestone for understanding the
biology of cells. Falcone and Mazzoni, in their minireview (doi:
10.1093/femsyr/foy050), summarize recent research on RNA sta-
bility and its connection with cell death and aging.
Target of Rapamycin (TOR) complex, the master regulator of
cell growth and amino acid sensing, and its downstream effec-
tor Sch9 have been implicated in various age-related disorders.
The Mini Review by Deprez et al. (doi:10.1093/femsyr/foy048)
outline the current knowledge on the molecular mechanisms
throughwhich the TORC1–Sch9 signaling axis regulates lifespan
in S. cerevisiae, unraveling the connections of TORC1 and Sch9
with yeast ageing by showing how downregulating TORC1–Sch9
signaling promotes lifespan extension by inducing a variety of
physiological changes, thus providing additional clues on how
their mammalian orthologues contribute to the mechanisms
underpinning human ageing and health. In this context theMini
Review by Teng et al. (FEMSYR-18-02-0041) described theWhi2 as
a newly identified negative regulator of cell growth in low amino
acids although to date the biochemical functions of Whi2 re-
main unknown. The KCTD (potassium channel tetramerization
domain) family proteins are shown as the mammalian homo-
logues ofWhi2 and cross-talk among nutrient sensing pathways
is described.
The diversity of mechanisms controlling proteostasis
in yeast is reviewed by Sampaio-Marques and Ludovico
(doi:10.1093/femsyr/foy043), with particular emphasis on the
developments that highlight the multidimensional nature of
the proteostasis network as well as the age-dependent changes
of this network.
Although microbial cells are considered unicellular organ-
isms, they can form organized multicellular communities. The
study of yeast cells in colonies provides some clues on multicel-
lular development. In the minireview by Vachova and Palkova
(doi: 10.1093/femsyr/foy033) are presentedmetabolic differences
between particular yeast communities as well as the presence
and functions of various differentiated cells, providing examples
of the ability of these cells to develop different ways to copewith
stress during community development and ageing.
Mitochondria are key cell organelles with a prominent role
in both energetic metabolism and the maintenance of cellular
homeostasis. The Mini Review by Guaragnella et al. (FEMSYR-
18-03-0071) focuses on the key pathways that mediate nucleus–
cytosol–mitochondria communications through both transcrip-
tional regulation and proteostatic signaling. It highlights yeast
that likely continues to serve as a productive model organ-
ism for mitochondrial research in the years to come. This is
further featured in the overview of mitochondrial biology as
known through yeast research, authored by Malina et al. (doi:
10.1093/femsyr/foy040). The authors provide an attractive out-
look on how systems biology studies, including mathematical
modeling, have allowed gaining new insight into mitochondrial
function, and argue that this approach may enable us to gain a
holistic view on how mitochondrial function interacts with dif-
ferent cellular processes.
Finally, yeast can be used as a platform for anti-aging drug
discovery. For example, yeast-based studies led to the discov-
ery of resveratrol or spermidine as potential anti-aging agents.
Zimmermann et al. (FEMSYR-17-12-0215.R1) in their minireview
present strategies for pharmacological anti-aging screens in
yeast, discuss common difficulties and present recent studies
that have used yeast for discovering both new drugs and their
target.
Conflict of interest. none declare.
REFERENCES
Carmona-Gutierrez D, Bauer MA, Zimmermann A et al. Guide-
lines and recommendations on yeast cell death nomencla-
ture. EMBO Rep 2018;5:1875–84.
Kuzmin E, VanderSluis B, Wang W et al. Systematic analysis of
complex genetic interactions. Science 2018;360:eaao1729.
Madeo F, Frohlich E, Frohlich KU. A yeast mutant showing
diagnostic markers of early and late apoptosis. J Cell Biol
1997;139:729–34.
Pretorius IS. Solving yeast jigsaw puzzles over a glass of wine:
Synthetic genome engineering pioneers new possibilities for
wine yeast research. EMBO Rep 2017;18:1875–84.
Sergio Giannattasio
Institute of Biomembranes, Bioenergetics and Molecular
Biotechnologies,National Research Council, Via Amendola
165/a, I-70126 Bari, Italy
E-mail: s.giannattasio@ibiom.cnr.it
Cristina Mazzoni
Department of Biology and Biotechnologies “C. Darwin”,
University of Rome “Sapienza”, Piazzale A. Moro 5, I-00185
Rome, Italy
D
ow
nloaded from
 https://academ
ic.oup.com
/fem
syr/article-abstract/18/8/foy083/5089637 by Sapienza U
niversità di R
om
a user on 19 O
ctober 2018
